Navigation Links
Notre Dame researcher's paper examines the biology of tumor-derived microvesicles
Date:6/21/2012

A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.

The World Health Organization (WHO) estimates that the incidence of cancer will reach approximately 9 million deaths in 2015. The rising prevalence of the disease is a major factor that drives the growth of the oncology biomarkers market. Biomarkers can be defined as any biological, chemical or physical parameter that can be utilized as an indicator of physiological or disease status. Thus, biomarkers are useful in cancer screening and detection, drug design and also to boost the effectiveness of cancer care by allowing physicians to tailor therapies for individual patientsan approach known as personalized medicine.

The new paper discusses the potential of microvesicles to present a combination of disease and tissue-specific markers that would constitute a unique, specific and identifiable biosignature for individual cancers.

"As such, it would make their sampling over time a preferred method to monitor changes to the tumor in response to treatment, especially for tissues such as the ovary or pancreas, where repeated biopsies of these organs is impractical," D'Souza-Schorey said.

Profiling of microvesicles could form the basis of personalized, targeted cancer therapies, especially as more reliable and rapid profiling technologies become available.

"For example, certain markers like HER2/neu, in addition to being elevated in breast cancer, is also increased in a relatively smaller subset of other cancers such as ovarian cancer," D'Souza-Schorey said. "This latter group of patients would benefit from existing treatment strategies that target the HER2 receptor."

The approach could be advantageous over currently used approaches of profiling whole tissue or un-fractionated body fluid particularly if circulating microvesicles indeed concentrate molecular changes that occur in the tumor, as it would increase the sensitivity of detecting critical markers of cancer progression.

"One complicating factor, though, is the presence of shed vesicles from other non-tumor cell types also in direct contact with these body fluids," D'Souza-Schorey said. "Thus, equally significant is the development of strategies to selectively capture tumor-specific markers that separate from other shed vesicle populations."

In collaboration with local oncologists, the D'Souza-Schorey laboratory is investigating the potential of microvesicles as a cancer diagnostic platform, a project under the umbrella of Notre Dame's Advanced Diagnostics and Therapeutics Initiative. The lab's research on the biology of microvesicles and their roles in tumor progression is supported by the National Cancer Institute and the Indiana Clinical and Translational Sciences Institute.

"Despite considerable strides, effort and investment in cancer biomarker research in the past decade, there are still more desirable outcomes, most especially enhanced sensitivity to enable early detection ," D'Souza-Schorey said. "An effective biomarker platform that will overcome these challenges would be paradigm shifting in cancer care."

The paper, which appears in the June 15 issue of the journal Genes and Development, was coauthored by Notre Dame graduate student James Clancy.


'/>"/>

Contact: Crislyn-D'Souza-Schorey
cdsouzas@nd.edu
574-631-3735
University of Notre Dame
Source:Eurekalert

Related medicine news :

1. Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
2. Moffitt researchers: Darwins principles say cancer will always evolve to resist treatment
3. Controversial vaccine trial should never have been run in India, researchers say
4. Researchers create the first GPS for the blind
5. Researchers find gold nanoparticles capable of unzipping DNA
6. Cedars-Sinai researchers, with stem cells, advance understanding of spinal muscular atrophy
7. Researchers reveal crucial immune fighter role of the STING protein
8. MDS researchers join forces to advance patient treatments and outcomes
9. Stanford researchers discover the African cichlids noisy courtship ritual
10. Researchers determine pathway for origin of most common form of brain and spinal cord tumor
11. UCI researchers create mosquitoes incapable of transmitting malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Diagnotes, a leader ... Health, a three hospital system in South Carolina, to provide its secure mobile ... technology that enhances communication, drives workflow efficiencies and improves provider and patient satisfaction,” ...
(Date:5/3/2016)... Boston, MA (PRWEB) , ... May 03, 2016 , ... ... where clinicians can rehearse tough medical situations or practice tricky or rare procedures in ... Longwood Medical Area, the SIM Center is also available to inventors and “hackers” to ...
(Date:5/3/2016)... Toledo, OH (PRWEB) , ... May 03, 2016 , ... ... remain a leading cause of death across the United States and account for one ... physical and mental impairments or are permanently disabled. HCR ManorCare is launching a video ...
(Date:5/3/2016)... ... 03, 2016 , ... Ogawa World USA introduced the first of its kind ... exclusive Smart Application. The Smart 3D combines the best in technological advancement, design, and ... profile and specialized massage program, each user has a tailored experience unparalleled by any ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... healthcare industry, announced today that Legacy Health is expanding its use of Intrigma’s ... after a highly successful initial proof of concept. The Portland, Oregon based health ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 Research and Markets has ... Products Market 2016-2020" report to their offering. ... The global plastic surgery products market is expected ... period 2016-2020. , ,The growing adoption of laser in ... of the market. Lasers are used to treat a ...
(Date:4/28/2016)... Treato , the single ... today that it has been named a Cool Vendor ... Life Sciences, 2016, Stephen Davies , ... on life-science- oriented analytics, algorithms and smart machine technology ... confirm medication ingestion, and analyze unstructured information.   ...
(Date:4/28/2016)... , April 28, 2016   Acsis , ... announced that leading IT market research and advisory firm ... in the IDC MarketScape: Worldwide Pharmaceutical Track and Trace ... The report provides an assessment of the capabilities and ... and trace software market. Logo - ...
Breaking Medicine Technology: